Evaluation method Results were assessed using three methods: (1) SALT (Severity of Alopecia Tool) scoring, (2) blinded dermatologist evaluation of before/after photographs, and (3) AI-assisted assessment using ChatGPT
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
If youre heading to the doctor to get a B12 shot, theres no need to prepare
Shimada K, Filipuzzi I, Stahl M, Helliwell SB, Studer C, Hoepfner D, et al
Conservative therapy cannot get rid of the obstructions, which makes Meibomian gland probing (MGP) medically appropriate